Close-up of an ECG report

The FDA today approved a new use for the diabetes drug, dapagliflozin (Farxiga), to reduce the risk of a hospital stay or death in people who have a type of heart failure.

LEAVE A REPLY

Please enter your comment!
Please enter your name here